A comparison between upfront high-dose tirofiban versus provisional use in the real-world of the non-selected STEMI patients undergoing primary PCI.

There is no fulltext present in this item.

Title:	A comparison between upfront high-dose tirofiban versus provisional use in the real-world of the non-selected STEMI patients undergoing primary PCI.
Author(s):	Heestermans, A.A.; Hermanides, R.S.; Gosselink, A.T.M.; Boer, M.J. de ; Hoorntje, J.C.A.; Suryapranata, H. ; Ottervanger, J.P.; Dambrink, J.H.; Kolkman, E.G.W. ; Berg, J.M. ten; Zijlstra, F.; Hof, A.W. van 't
Publication year:	2010
Source:	Netherlands Heart Journal, vol. 18, iss. 12, (2010), pp. 592-597
ISSN:	1568-5888
DOI:	https://doi.org/10.1007/s12471-010-0840-z
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/89388
Display more details
Subject:	NCEBP 14: Cardiovascular diseases
Organization:	Cardiology Radboudumc Extern Otorhinolaryngology
Journal title:	Netherlands Heart Journal
Volume:	vol. 18
Issue:	iss. 12
Page start:	p. 592
Page end:	p. 597